Medicis, Solodyn Buyers Duel For Quick Wins In Antitrust MDL
Medicis Pharmaceutical Corp. and two classes of Solodyn buyers have each asked a Massachusetts federal court for quick wins to end the buyers' pay-for-delay suit accusing Medicis of paying generic-drug makers...To view the full article, register now.
Already a subscriber? Click here to view full article